Such dynamic changes in BRD9’s regulatory roles and its target specificity support the functioning of BRD9 as a metabolic checkpoint to fine-tune the energetic state and progressive fate of PCa cells. This evidence concerns the gene BRD9 and posterior cortical atrophy.